Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bosinger, Steven E."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-13 z 13
    Tytuł:
    High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope.
    Autorzy:
    Mopuri R; Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Welbourn S; Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Charles T; Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Ralli-Jain P; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
    Rosales D; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
    Burton S; Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Aftab A; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
    Karunakaran K; Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Pellegrini K; Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Kilembe W; Center for Family Health Research in Zambia, Lusaka, Zambia.
    Karita E; Center for Family Health Research, Kigali, Rwanda.
    Gnanakaran S; Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
    Upadhyay AA; Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
    Bosinger SE; Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
    Derdeyn CA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.; Infectious Diseases and Translational Medicine Unit, Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2023 Oct 25; Vol. 19 (10), pp. e1011717. Date of Electronic Publication: 2023 Oct 25 (Print Publication: 2023).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    HIV-1*
    HIV Infections*
    HIV Seropositivity*
    AIDS Vaccines*
    Animals ; Antibodies, Neutralizing ; Macaca mulatta ; HIV Antibodies ; Immunization ; env Gene Products, Human Immunodeficiency Virus
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques.
    Autorzy:
    Byrnes SJ; School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.
    Busman-Sahay K; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
    Angelovich TA; School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.; Life Science, Burnet Institute, Melbourne, Australia.; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
    Younger S; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
    Taylor-Brill S; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
    Nekorchuk M; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
    Bondoc S; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
    Dannay R; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
    Terry M; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
    Cochrane CR; School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.
    Jenkins TA; School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.
    Roche M; School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
    Deleage C; AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Bosinger SE; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Paiardini M; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Brew BJ; Peter Duncan Neurosciences Unit, Departments of Neurology and Immunology St Vincent's Hospital, University of New South Wales and University of Notre Dame, Sydney, New South Wales, Australia.
    Estes JD; School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
    Churchill MJ; School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.; Life Science, Burnet Institute, Melbourne, Australia.; Departments of Microbiology and Medicine, Monash University, Clayton, Australia.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2023 Mar 29; Vol. 19 (3), pp. e1011290. Date of Electronic Publication: 2023 Mar 29 (Print Publication: 2023).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Simian Acquired Immunodeficiency Syndrome*/drug therapy
    Simian Immunodeficiency Virus*
    HIV Infections*
    Animals ; Macaca mulatta ; Neuroinflammatory Diseases
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The role of CD101-expressing CD4 T cells in HIV/SIV pathogenesis and persistence.
    Autorzy:
    Strongin Z; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.
    Hoang TN; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.
    Tharp GK; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.
    Rahmberg AR; Barrier Immunity Section, Laboratory of Viral Diseases, NIAID, NIH; Bethesda, Maryland, United States of America.
    Harper JL; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.
    Nguyen K; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.
    Franchitti L; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.
    Cervasi B; Flow Cytometry Core, Emory Vaccine Center, Emory University; Atlanta, Georgia, United States of America.
    Lee M; Vaccine Research Center, National Institutes of Health; Bethesda, Maryland, United States of America.
    Zhang Z; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.
    Boritz EA; Vaccine Research Center, National Institutes of Health; Bethesda, Maryland, United States of America.
    Silvestri G; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine; Atlanta, Georgia, United States of America.; Division of Infectious Diseases, Emory University School of Medicine; Atlanta, Georgia, United States of America.
    Marconi VC; Division of Infectious Diseases, Emory University School of Medicine; Atlanta, Georgia, United States of America.; Division of Infectious Diseases Research, Atlanta Veterans Affairs Medical Center; Atlanta, Georgia, United States of America.; Rollins School of Public Health, Emory University; Atlanta, Georgia, United States of America.; Emory Vaccine Center, Atlanta, Georgia, United States of America.
    Bosinger SE; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine; Atlanta, Georgia, United States of America.
    Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, NIAID, NIH; Bethesda, Maryland, United States of America.
    Kulpa DA; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine; Atlanta, Georgia, United States of America.
    Paiardini M; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University; Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine; Atlanta, Georgia, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2022 Jul 22; Vol. 18 (7), pp. e1010723. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
    MeSH Terms:
    HIV Infections*/metabolism
    Simian Acquired Immunodeficiency Syndrome*
    Simian Immunodeficiency Virus*
    Animals ; CD4-Positive T-Lymphocytes ; Humans ; Macaca mulatta
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence.
    Autorzy:
    Welbourn S; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Chakraborty S; Theoretical Biology and Biophysics Group, Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
    Yang JE; Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
    Gleinich AS; Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, United States of America.
    Gangadhara S; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Khan S; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Ferrebee C; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Yagnik B; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Burton S; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Charles T; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Smith SA; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Williams D; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Mopuri R; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Upadhyay AA; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Thompson J; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Price MA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America.; International AIDS Vaccine Initiative, New York city, New York, United States of America.
    Wang S; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
    Qin Z; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
    Shen X; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
    Williams LD; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
    Eisel N; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
    Peters T; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
    Zhang L; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
    Kilembe W; Center for Family Health Research in Zambia (CFHRZ), Lusaka, Zambia.
    Karita E; Projet San Francisco, Kigali, Rwanda.
    Tomaras GD; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
    Bosinger SE; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
    Amara RR; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.; Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, United States of America.
    Azadi P; Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, United States of America.
    Wright ER; Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
    Gnanakaran S; Theoretical Biology and Biophysics Group, Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
    Derdeyn CA; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2022 May 03; Vol. 18 (5), pp. e1010488. Date of Electronic Publication: 2022 May 03 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    AIDS Vaccines*
    HIV Infections*/prevention & control
    HIV-1*
    Animals ; Antibodies, Neutralizing ; HIV Antibodies ; HIV Envelope Protein gp120 ; Humans ; Macaca mulatta ; env Gene Products, Human Immunodeficiency Virus
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Infiltration of inflammatory macrophages and neutrophils and widespread pyroptosis in lung drive influenza lethality in nonhuman primates.
    Autorzy:
    Corry J; Department of Infectious Diseases & Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Kettenburg G; Department of Infectious Diseases & Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Upadhyay AA; Yerkes NHP Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Wallace M; Department of Infectious Diseases & Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Marti MM; Department of Infectious Diseases & Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Wonderlich ER; Department of Infectious Diseases & Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Bissel SJ; Division of Neuropathology, Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Goss K; Yerkes NHP Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Sturgeon TJ; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Watkins SC; Department of Cell Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Reed DS; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Bosinger SE; Yerkes NHP Genomics Core Laboratory, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
    Barratt-Boyes SM; Department of Infectious Diseases & Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2022 Mar 10; Vol. 18 (3), pp. e1010395. Date of Electronic Publication: 2022 Mar 10 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Influenza A Virus, H5N1 Subtype*
    Orthomyxoviridae Infections*/immunology
    Animals ; Interferons/immunology ; Lung ; Macrophages, Alveolar/immunology ; Neutrophils/immunology ; Primates ; Pyroptosis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Tissue-specific transcriptional profiling of plasmacytoid dendritic cells reveals a hyperactivated state in chronic SIV infection.
    Autorzy:
    Lee MY; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Upadhyay AA; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Walum H; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Chan CN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
    Dawoud RA; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Grech C; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Harper JL; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Karunakaran KA; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Nelson SA; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Mahar EA; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Goss KL; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Carnathan DG; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Cervasi B; Flow Cytometry Core, Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America.
    Gill K; Flow Cytometry Core, Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America.
    Tharp GK; Yerkes NHP Genomics Core Laboratory, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Wonderlich ER; Southern Research, Frederick, Maryland, United States of America.
    Velu V; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, United States of America.
    Barratt-Boyes SM; Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
    Paiardini M; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, United States of America.
    Silvestri G; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, United States of America.
    Estes JD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
    Bosinger SE; Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.; Yerkes NHP Genomics Core Laboratory, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2021 Jun 28; Vol. 17 (6), pp. e1009674. Date of Electronic Publication: 2021 Jun 28 (Print Publication: 2021).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Dendritic Cells/*immunology
    Simian Acquired Immunodeficiency Syndrome/*immunology
    Animals ; Cercocebus atys ; Gene Expression Profiling ; Macaca mulatta ; RNA-Seq ; Transcriptome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Clinical and whole genome characterization of SARS-CoV-2 in India.
    Autorzy:
    Muttineni R; Virus Research Laboratory, Department of Zoology, Osmania University, Hyderabad, India.
    Kammili N; Department of Microbiology, Gandhi Medical College and Hospital, Secunderabad, India.
    Bingi TC; Department of General Medicine, Gandhi Medical College and Hospital, Secunderabad, India.
    Rao M R; Department of General Medicine, Gandhi Medical College and Hospital, Secunderabad, India.
    Putty K; Department of Veterinary Biotechnology, College of Veterinary Science, Rajendranagar, PVNR Telangana Veterinary University, Hyderabad, India.
    Dholaniya PS; Department of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, India.
    Puli RK; Telangana State Council for Science and Technology, Government of Telangana, Hyderabad, India.
    Pakalapati S; Department of Microbiology, Gandhi Medical College and Hospital, Secunderabad, India.
    S S; Department of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, India.
    K S; Virus Research Laboratory, Department of Zoology, Osmania University, Hyderabad, India.
    Doodipala MR; Department of Mathematics, GITAM University, Hyderabad, India.
    Upadhyay AA; Department of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States of America.
    Bosinger SE; Department of Pathology and Laboratory Medicine, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States of America.
    Amara RR; Department of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States of America.
    Kondapi AK; Department of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, India.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2021 Feb 02; Vol. 16 (2), pp. e0246173. Date of Electronic Publication: 2021 Feb 02 (Print Publication: 2021).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Genome, Viral*
    Whole Genome Sequencing*
    COVID-19/*virology
    SARS-CoV-2/*genetics
    Adult ; Aged ; Angiotensin-Converting Enzyme 2/chemistry ; Angiotensin-Converting Enzyme 2/metabolism ; COVID-19/immunology ; COVID-19/pathology ; Female ; Humans ; India ; Male ; Middle Aged ; Phylogeny ; RNA, Viral/genetics ; SARS-CoV-2/isolation & purification ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Innate, non-cytolytic CD8+ T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription.
    Autorzy:
    Zanoni M; Division of Microbiology and Immunology, Yerkes National Primate Research Center, and Emory Vaccine Center Emory University, Atlanta, Georgia, United States of America.
    Palesch D; Division of Microbiology and Immunology, Yerkes National Primate Research Center, and Emory Vaccine Center Emory University, Atlanta, Georgia, United States of America.
    Pinacchio C; Division of Microbiology and Immunology, Yerkes National Primate Research Center, and Emory Vaccine Center Emory University, Atlanta, Georgia, United States of America.
    Statzu M; Division of Microbiology and Immunology, Yerkes National Primate Research Center, and Emory Vaccine Center Emory University, Atlanta, Georgia, United States of America.
    Tharp GK; Division of Microbiology and Immunology, Yerkes National Primate Research Center, and Emory Vaccine Center Emory University, Atlanta, Georgia, United States of America.
    Paiardini M; Division of Microbiology and Immunology, Yerkes National Primate Research Center, and Emory Vaccine Center Emory University, Atlanta, Georgia, United States of America.
    Chahroudi A; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Bosinger SE; Division of Microbiology and Immunology, Yerkes National Primate Research Center, and Emory Vaccine Center Emory University, Atlanta, Georgia, United States of America.
    Yoon J; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Cox B; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Silvestri G; Division of Microbiology and Immunology, Yerkes National Primate Research Center, and Emory Vaccine Center Emory University, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Kulpa DA; Division of Microbiology and Immunology, Yerkes National Primate Research Center, and Emory Vaccine Center Emory University, Atlanta, Georgia, United States of America.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2020 Sep 17; Vol. 16 (9), pp. e1008821. Date of Electronic Publication: 2020 Sep 17 (Print Publication: 2020).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Immunity, Innate*
    CD8-Positive T-Lymphocytes/*immunology
    HIV-1/*physiology
    Histocompatibility Antigens Class I/*immunology
    Transcription, Genetic/*immunology
    Virus Replication/*immunology
    Animals ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; Cell Proliferation ; Humans ; Macaca
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Innate, non-cytolytic CD8 T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription.
    Autorzy:
    Zanoni, Michelle (AUTHOR)
    Palesch, David (AUTHOR)
    Pinacchio, Claudia (AUTHOR)
    Statzu, Maura (AUTHOR)
    Tharp, Gregory K. (AUTHOR)
    Paiardini, Mirko (AUTHOR)
    Chahroudi, Ann (AUTHOR)
    Bosinger, Steven E. (AUTHOR)
    Yoon, Jack (AUTHOR)
    Cox, Bryan (AUTHOR)
    Silvestri, Guido (AUTHOR)
    Kulpa, Deanna A. (AUTHOR)
    Pokaż więcej
    Źródło:
    PLoS Pathogens. 9/17/2020, Vol. 16 Issue 9, p1-24. 24p.
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication.
    Autorzy:
    Nganou-Makamdop K; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Billingsley JM; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Yaffe Z; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    O'Connor G; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Tharp GK; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.
    Ransier A; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Laboune F; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Matus-Nicodemos R; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Lerner A; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Gharu L; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Robertson JM; Department of Surgery and Emory Transplant Center, Emory University School of Medicine and Emory Healthcare, Atlanta, GA.
    Ford ML; Department of Surgery and Emory Transplant Center, Emory University School of Medicine and Emory Healthcare, Atlanta, GA.
    Schlapschy M; Lehrstuhl für Biologische Chemie, Technische Universität München, Freising (Weihenstephan), Germany.
    Kuhn N; Lehrstuhl für Biologische Chemie, Technische Universität München, Freising (Weihenstephan), Germany.
    Lensch A; Lehrstuhl für Biologische Chemie, Technische Universität München, Freising (Weihenstephan), Germany.
    Lifson J; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Nason M; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
    Skerra A; Lehrstuhl für Biologische Chemie, Technische Universität München, Freising (Weihenstephan), Germany.; XL-protein GmbH, Freising, Germany.
    Schreiber G; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
    Bosinger SE; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.; Department of Pathology & Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
    Douek DC; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2018 Aug 24; Vol. 14 (8), pp. e1007246. Date of Electronic Publication: 2018 Aug 24 (Print Publication: 2018).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
    MeSH Terms:
    Simian Acquired Immunodeficiency Syndrome*/drug therapy
    Simian Acquired Immunodeficiency Syndrome*/immunology
    Simian Acquired Immunodeficiency Syndrome*/virology
    Anti-Retroviral Agents/*pharmacology
    Inflammation/*prevention & control
    Interferon Type I/*antagonists & inhibitors
    T-Lymphocytes/*drug effects
    Virus Replication/*drug effects
    Animals ; Anti-Retroviral Agents/therapeutic use ; Chronic Disease ; Inflammation/immunology ; Inflammation/virology ; Interferon Type I/metabolism ; Lymphocyte Activation/drug effects ; Macaca mulatta ; Receptors, Interferon/antagonists & inhibitors ; Signal Transduction/drug effects ; Signal Transduction/immunology ; Simian Immunodeficiency Virus/drug effects ; Simian Immunodeficiency Virus/immunology ; Simian Immunodeficiency Virus/physiology ; T-Lymphocytes/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Coexpression Network Analysis of Benign and Malignant Phenotypes of SIV-Infected Sooty Mangabey and Rhesus Macaque.
    Autorzy:
    Yang ZW; Hubei Bioinformatics and Molecular Imaging Key Laboratory, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
    Jiang YH; Hubei Bioinformatics and Molecular Imaging Key Laboratory, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
    Ma C; Saban Research Institute of Children's Hospital Los Angeles, Department of Pediatrics, University of Southern California, Los Angeles, California, United States of America.
    Silvestri G; Yerkes National Primate Research Center, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Bosinger SE; Yerkes National Primate Research Center, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Li BL; Ecological Complexity and Modeling Laboratory, University of California Riverside, Riverside, CA 92521-0124, United States of America.
    Jong A; Saban Research Institute of Children's Hospital Los Angeles, Department of Pediatrics, University of Southern California, Los Angeles, California, United States of America.
    Zhou YH; Hubei Bioinformatics and Molecular Imaging Key Laboratory, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
    Huang SH; Hubei Bioinformatics and Molecular Imaging Key Laboratory, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.; Saban Research Institute of Children's Hospital Los Angeles, Department of Pediatrics, University of Southern California, Los Angeles, California, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Jun 09; Vol. 11 (6), pp. e0156170. Date of Electronic Publication: 2016 Jun 09 (Print Publication: 2016).
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    Gene Regulatory Networks*
    Cercocebus atys/*genetics
    Macaca mulatta/*genetics
    Simian Acquired Immunodeficiency Syndrome/*genetics
    Simian Immunodeficiency Virus/*isolation & purification
    Animals ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/metabolism ; CD4-Positive T-Lymphocytes/virology ; Cercocebus atys/immunology ; Cercocebus atys/virology ; Immunity, Innate/genetics ; Immunity, Innate/immunology ; Macaca mulatta/immunology ; Macaca mulatta/virology ; Oligonucleotide Array Sequence Analysis ; Signal Transduction ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Acquired Immunodeficiency Syndrome/virology ; Species Specificity
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals.
    Autorzy:
    Klatt NR; Department of Pharmaceutics, Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Bosinger SE; Yerkes Primate Research Center, Emory Vaccine Center and Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
    Peck M; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
    Richert-Spuhler LE; Department of Pharmaceutics, Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
    Heigele A; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
    Gile JP; Department of Pharmaceutics, Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
    Patel N; Yerkes Primate Research Center, Emory Vaccine Center and Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
    Taaffe J; Yerkes Primate Research Center, Emory Vaccine Center and Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
    Julg B; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America.
    Camerini D; Institute for Immunology, University of California Irvine, Irvine, California, United States of America.
    Torti C; Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy.
    Martin JN; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
    Deeks SG; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
    Sinclair E; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
    Hecht FM; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
    Lederman MM; Division of Infectious Diseases, Case Western Reserve University/University Hospitals Case Medical Center, Cleveland, Ohio, United States of America.
    Paiardini M; Yerkes Primate Research Center, Emory Vaccine Center and Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
    Kirchhoff F; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
    Brenchley JM; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
    Hunt PW; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
    Silvestri G; Yerkes Primate Research Center, Emory Vaccine Center and Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2014 Aug 28; Vol. 10 (8), pp. e1004345. Date of Electronic Publication: 2014 Aug 28 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    CD4-Positive T-Lymphocytes/*immunology
    HIV Infections/*immunology
    Immunologic Memory/*immunology
    T-Lymphocyte Subsets/*immunology
    Viremia/*immunology
    CD4-Positive T-Lymphocytes/virology ; Cell Separation ; DNA, Viral/analysis ; Disease Progression ; HIV Infections/virology ; Humans ; Immunophenotyping ; Oligonucleotide Array Sequence Analysis ; Stem Cells/immunology ; Stem Cells/virology ; T-Lymphocyte Subsets/virology ; Viral Load ; Viremia/virology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-13 z 13

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies